Schuetz F - Search Results

1

Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade.

Hennigs A, Riedel F, Marmé F, Sinn P, Lindel K, Gondos A, Smetanay K, Golatta M, Sohn C, Schuetz F, Heil J, Schneeweiss A. Hennigs A, et al. Among authors: schuetz f. Breast Cancer Res Treat. 2016 Dec;160(3):491-499. doi: 10.1007/s10549-016-4016-4. Epub 2016 Oct 15. Breast Cancer Res Treat. 2016. PMID: 27744486 Free PMC article.

2

Micrometastatic bone marrow cells at diagnosis have no impact on survival of primary breast cancer patients with extensive axillary lymph node involvement treated with stem cell-supported high-dose chemotherapy.

Schneeweiss A, Diel I, Hensel M, Kaul S, Sinn HP, Unnebrink K, Rudlowski C, Lauschner I, Schuetz F, Egerer G, Haas R, Ho AD, Bastert G. Schneeweiss A, et al. Among authors: schuetz f. Ann Oncol. 2004 Nov;15(11):1627-32. doi: 10.1093/annonc/mdh433. Ann Oncol. 2004. PMID: 15520063 Free article.

3

Dose-dense primary systemic chemotherapy with gemcitabine plus epirubicin sequentially followed by docetaxel for early breast cancer: final results of a phase I/II trial.

Schneeweiss A, Schuetz F, Rudlowski C, Hahn M, Lauschner I, Sinn HP, von Fournier D, Sohn C. Schneeweiss A, et al. Among authors: schuetz f. Anticancer Drugs. 2005 Oct;16(9):1023-8. doi: 10.1097/01.cad.0000176508.73090.fb. Anticancer Drugs. 2005. PMID: 16162980 Clinical Trial.

4

Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer.

Thuerigen O, Schneeweiss A, Toedt G, Warnat P, Hahn M, Kramer H, Brors B, Rudlowski C, Benner A, Schuetz F, Tews B, Eils R, Sinn HP, Sohn C, Lichter P. Thuerigen O, et al. Among authors: schuetz f. J Clin Oncol. 2006 Apr 20;24(12):1839-45. doi: 10.1200/JCO.2005.04.7019. J Clin Oncol. 2006. PMID: 16622258

5

Safety and pharmacokinetics of bivatuzumab mertansine in patients with CD44v6-positive metastatic breast cancer: final results of a phase I study.

Rupp U, Schoendorf-Holland E, Eichbaum M, Schuetz F, Lauschner I, Schmidt P, Staab A, Hanft G, Huober J, Sinn HP, Sohn C, Schneeweiss A. Rupp U, et al. Among authors: schuetz f. Anticancer Drugs. 2007 Apr;18(4):477-85. doi: 10.1097/CAD.0b013e32801403f4. Anticancer Drugs. 2007. PMID: 17351401 Clinical Trial.

6

Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.

Schuetz F, Diel IJ, Pueschel M, von Holst T, Solomayer EF, Lange S, Sinn P, Bastert G, Sohn C. Schuetz F, et al. Am J Obstet Gynecol. 2007 Apr;196(4):342.e1-9. doi: 10.1016/j.ajog.2006.10.901. Am J Obstet Gynecol. 2007. PMID: 17403414

7

Weekly administration of bendamustine as salvage therapy in metastatic breast cancer: final results of a phase II study.

Eichbaum MH, Schuetz F, Khbeis T, Lauschner I, Foerster F, Sohn C, Schneeweiss A. Eichbaum MH, et al. Among authors: schuetz f. Anticancer Drugs. 2007 Sep;18(8):963-8. doi: 10.1097/CAD.0b013e328165d11a. Anticancer Drugs. 2007. PMID: 17667603 Clinical Trial.

8

Oblimersen combined with docetaxel, adriamycin and cyclophosphamide as neo-adjuvant systemic treatment in primary breast cancer: final results of a multicentric phase I study.

Rom J, von Minckwitz G, Eiermann W, Sievert M, Schlehe B, Marmé F, Schuetz F, Scharf A, Eichbaum M, Sinn HP, Kaufmann M, Sohn C, Schneeweiss A. Rom J, et al. Among authors: schuetz f. Ann Oncol. 2008 Oct;19(10):1698-705. doi: 10.1093/annonc/mdn280. Epub 2008 May 13. Ann Oncol. 2008. PMID: 18477581 Free article. Clinical Trial.

9

Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-up.

Diel IJ, Jaschke A, Solomayer EF, Gollan C, Bastert G, Sohn C, Schuetz F. Diel IJ, et al. Among authors: schuetz f. Ann Oncol. 2008 Dec;19(12):2007-11. doi: 10.1093/annonc/mdn429. Epub 2008 Jul 29. Ann Oncol. 2008. PMID: 18664560 Free PMC article. Clinical Trial.

10

Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study.

Schuetz F, Ehlert K, Ge Y, Schneeweiss A, Rom J, Inzkirweli N, Sohn C, Schirrmacher V, Beckhove P. Schuetz F, et al. Cancer Immunol Immunother. 2009 Jun;58(6):887-900. doi: 10.1007/s00262-008-0605-3. Epub 2008 Nov 8. Cancer Immunol Immunother. 2009. PMID: 18998129 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters